📢 Glenmark Pharma Q2 Profit Soars on Strong Revenue & Margin Expansion

Glenmark Pharmaceuticals reported an impressive performance in Q2, with net profit jumping to ₹610 crore, significantly higher than ₹354 crore in the same period last year. Revenue also surged to ₹6,050 crore from ₹3,400 crore, showcasing strong demand and improved business momentum. EBITDA climbed sharply to ₹2,360 crore versus ₹610 crore year-on-year, while EBITDA margin strengthened remarkably to 39.03%, up from 17.88%, driven by improved operational efficiency. #GlenmarkPharma #Q2Results #EarningsUpdate #PharmaNews #StockMarketIndia #CorporateEarnings #ProfitGrowth #MarketUpdate